Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Number of holders
-
313
-
Total 13F shares, excl. options
-
41,222,454
-
Shares change
-
-283,020
-
Total reported value, excl. options
-
$3,630,167,945
-
Value change
-
-$10,769,148
-
Put/Call ratio
-
89.61%
-
Number of buys
-
147
-
Number of sells
-
-131
-
Price
-
$88.08
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2019
377 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2019.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,222,454 shares
of 44,798,018 outstanding shares and own 92.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4,641,085 shares), VANGUARD GROUP INC (4,052,047 shares), RENAISSANCE TECHNOLOGIES LLC (3,544,433 shares), FMR LLC (2,383,549 shares), STATE STREET CORP (1,894,825 shares), Palo Alto Investors LP (1,288,902 shares), CITADEL ADVISORS LLC (1,231,507 shares), MILLENNIUM MANAGEMENT LLC (1,112,923 shares), D. E. Shaw & Co., Inc. (959,171 shares), and Consonance Capital Management LP (919,263 shares).
This table shows the top 313 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.